A carregar...
CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia
Relapsed and refractory acute lymphoblastic leukemia (ALL) remains difficult to treat, with minimal improvement in outcomes seen in more than 2 decades despite advances in upfront therapy and improved survival for de novo ALL. Adoptive transfer of T cells engineered to express a chimeric antigen rec...
Na minha lista:
| Publicado no: | Blood |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Hematology
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4481592/ https://ncbi.nlm.nih.gov/pubmed/25999455 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-12-580068 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|